Methotrexate safety: from prescribing to labelling.
F
F
Al-Niaimi
N H
NH
Cox
D003879:Dermatologic Agents / Q000009:adverse effects*; D004348:Drug Labeling / Q000592:standards*; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects*; D010818:Practice Patterns, Physicians' / Q000592:standards*; D017751:Safety Management / Q000379:methods; D006113:United Kingdom
D003879:Dermatologic Agents; D008727:Methotrexate